Clinical Trial Update: Lisdexamphetamine Vs Methylphenidate for Pediatric Patients with ADHD and Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 head-to-head clinical trial compares lisdexamfetamine and methylphenidate for ADHD in pediatric patients with Type 1 diabetes and is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Type 1 Diabetes Mellitus

Drugs mentioned

• Methylphenidate (Methylphenidate)
• Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: Medical University of Lodz | Conditions: Attention Deficit Disorder with Hyperactivity, Diabetes Mellitus, Type 1 | Phase 2 | Status: RECRUITING